Ramulus Mori (Sangzhi) Alkaloids Alleviate High-Fat Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice
Open Access
- 5 May 2022
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 11 (5) , 905
Abstract
Nonalcoholic fatty liver disease (NAFLD), obesity, and type 2 diabetes mellitus (T2DM) have highly related mechanisms. Ramulus Mori (Sangzhi) alkaloids (SZ-A) from Morus alba L. were approved in 2020 for the treatment of T2DM. In this study, we examined the therapeutic effects and mechanism of SZ-A on obesity and NAFLD in mice. Mice (C57BL/6J) fed a high-fat diet (HFD) for 14 weeks were treated with SZ-A for another 6 weeks. HFD-induced weight gain was reduced by SZ-A in a dose-dependent manner. SZ-A treatment significantly stimulated adiponectin expression and secretion in adipose tissue and 3T3-L1 adipocytes. Additionally, SZ-A markedly reduced hepatic steatosis (triglyceride, total cholesterol) and expression of pro-inflammatory and pro-fibrotic genes. SZ-A regulated lipid metabolism and oxidative stress (malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx), and glutathione (GSH)) in the liver. Palmitic acid-induced insulin resistance and lipid accumulation in HepG2 cells were also repressed by SZ-A. Collectively, SZ-A protected mice from HFD-induced NAFLD through an indirect effect of improved systemic metabolism reducing bodyweight, and a direct effect by enhancing the lipid metabolism of HepG2 cells. The weight-loss effect of SZ-A in mice was partly due to improved fatty oxidation instead of influencing food consumption.Keywords
Funding Information
- Beijing Postdoctoral Science Foundation (2021-ZZ-043, 2021-I2M-1-028)
- CAMS Innovation Fund for Medical Sciences (2021-ZZ-043, 2021-I2M-1-028)
This publication has 42 references indexed in Scilit:
- Adipokines in nonalcoholic fatty liver diseaseMetabolism, 2016
- Mitochondria‐targeted antioxidantsThe FASEB Journal, 2015
- 1-Deoxynojirimycin isolated from Bacillus subtilis improves hepatic lipid metabolism and mitochondrial function in high-fat–fed miceFood and Chemical Toxicology, 2015
- The role of hepatic lipids in hepatic insulin resistance and type 2 diabetesNature, 2014
- Multiple Hits, Including Oxidative Stress, as Pathogenesis and Treatment Target in Non-Alcoholic Steatohepatitis (NASH)International Journal of Molecular Sciences, 2013
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosisNature Reviews Gastroenterology & Hepatology, 2013
- Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1Nature, 2010
- Targeted Expression of Uncoupling Protein 2 to Mouse Liver Increases the Susceptibility to Lipopolysaccharide/Galactosamine-Induced Acute Liver Injury†Hepatology, 2009
- How mitochondria produce reactive oxygen speciesBiochemical Journal, 2008
- Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actionsNature Medicine, 2007